Acesso livre
Acesso livre

Cardiologia

Aspirina para prevenção cardiovascular primária em pacientes com diabetes: incertezas e oportunidades.

14 Abr, 2022 | 16:43h

Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities – Thrombosis and Haemostasis

Diretriz relacionada: USPSTF draft statement revises previous guidance and now recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults aged 60 years or older.

Estudos randomizados relacionados:

Randomized Trial: Aspirin for Primary Prevention of Cardiovascular Disease

Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes

Randomized Trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

Metanálises relacionadas:

Meta-Analysis: Association of Aspirin Use for Primary Prevention with Cardiovascular Events and Bleeding Events

Meta-Analysis: Efficacy and Safety of Aspirin for Primary Prevention of Cardiovascular Events

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups – BMC Medicine

Opiniões relacionadas:

Aspirin for Primary Prevention: Is This the End of the Road?

Evidence evolving on aspirin as prevention – ACP Internist

Editorial | Quem? Quando? Onde? Como? Opiniões sobre ressuscitação cardiopulmonar extracorpórea.

14 Abr, 2022 | 16:40h

Who? When? Where? How? Still the alpha and omega of extracorporeal cardiopulmonary resuscitation – European Heart Journal. Acute Cardiovascular Care

Estudo original: The association between time to extracorporeal cardiopulmonary resuscitation and outcome in patients with out-of-hospital cardiac arrest – European Heart Journal. Acute Cardiovascular Care (link para o resumo – $ para o texto completo)

Conteúdos relacionados:

RCT: In patients with refractory out-of-hospital cardiac arrest, a strategy of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment did not significantly improve survival with a favorable neurological outcome (OR 1.63; 95% CI 0.93 to 2.85; P = .09).

Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications.

Guidelines for extracorporeal cardiopulmonary resuscitation in children and adults

 

Comentário no Twitter

 

Estudo de coorte | Insônia está associada a risco aumentado de eventos cardiovasculares recorrentes em pacientes com doença cardíaca coronariana.

14 Abr, 2022 | 16:35h

Insomnia as a predictor of recurrent cardiovascular events in patients with coronary heart disease – Sleep Advances

Comentário: Insomnia is linked with recurrent heart events in coronary patients – European Society of Cardiology

Revisão de diretrizes nacionais | Fase aguda da doença de Kawasaki.

14 Abr, 2022 | 16:31h

Acute phase of Kawasaki disease: a review of national guideline recommendations – European Journal of Pediatrics

Estudo randomizado | O tempo para a ablação da taquicardia ventricular afeta o prognóstico de pacientes com desfibrilador cardioversor implantável?

14 Abr, 2022 | 16:25h

Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial – Circulation

Comentário: Don’t Wait, Ablate to Prevent VT Episodes After an ICD Shock?— Early catheter ablation reduced deaths and ICD shocks in PARTITA trial – MedPage Today (necessário cadastro gratuito)

Revisão | Regurgitação mitral secundária: quando encaminhar, quando tratar e como tratar?

14 Abr, 2022 | 16:19h

Secondary Mitral Regurgitation: When to Refer, When to Treat and How to Treat? – American College of Cardiology

Conteúdos relacionados:

ESC Position Statement: Management of secondary mitral regurgitation in patients with heart failure

Randomized Trial: Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Cohort study: Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure.

Meta-analysis: Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation

Revisão | Fibrilação atrial.

12 Abr, 2022 | 12:46h

Atrial fibrillation – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

Infográfico: Atrial fibrillation – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

 

Estudo randomizado | Promoção no Twitter está associada a maiores taxas de citação de artigos cardiovasculares.

12 Abr, 2022 | 12:41h

Twitter promotion is associated with higher citation rates of cardiovascular articles: the ESC Journals Randomized Study – European Society of Cardiology (link para o resumo – $ para o texto completo)

Conteúdos relacionados:

Randomized Trial: Twitter Promotion Increases Citation Rates of Cardiovascular Articles

Does Tweeting Improve Citations? One-Year Results from the TSSMN Prospective Randomized Trial

A critical review on altmetrics: can we measure the social impact factor?

As scientists take to Twitter, study shows power of ‘visual abstract’ graphics

Riding the Twitter wave: Enthusiasm for the social media platform changed science communication during the pandemic—but will it last?

Optimizing the use of Twitter for research dissemination: The “Three Facts and a Story” randomized-controlled trial.

Perspective: How Twitter is Changing Medical Research

Keeping Up With Cardiology: Old-School Learning Versus the Twittersphere – TCTMD

Scientists on Twitter: Preaching to the choir or singing from the rooftops? – Facets

Rise of the Tweetorial – Precious Bodily Fluids

Social Medicine: Twitter in Healthcare – Journal of Clinical Medicine

University of Twitter? Scientists give impromptu lecture critiquing nutrition research – CBC

Twitter-Based Medicine: How Social Media is Changing the Public’s View of Medicine – The Health Care Blog

What’s your doctor reading? How social media is disrupting medical education – National Post

Diretriz científica AHA | Abordagem dos determinantes sociais de saúde e mitigação de disparidades de saúde ao longo da vida na doença cardíaca congênita.

12 Abr, 2022 | 12:29h

Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association – Circulation

Comentário: Social determinants of health affect care for people with congenital heart disease – American Heart Association

Ampla base de dados com 10 registros ou estudos clínicos mostra que o implante de valva aórtica transcateter (transcatheter aortic valve implantation – TAVI) valva-em-valva resultou em mortalidade e taxas de AVC similares em comparação a TAVI nativa.

12 Abr, 2022 | 12:16h

Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation – American Journal of Cardiology

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.